Study: Fewer than 10% of people in the US had detectable SARS-CoV-2 antibodies as of September 2020
30 Nov, 2020 | 01:00h | UTCEstimated SARS-CoV-2 Seroprevalence in the US as of September 2020 – JAMA Internal Medicine
Commentaries: Less than 10% of Americans had COVID by September, study finds – CIDRAP AND Antibodies, Immunity, and COVID-19 – JAMA Internal Medicine AND Covid-19: Nationwide SARS-CoV-2 Seroprevalence Remains Low – Physician’s Weekly
Commentary on Twitter
.@CDCgov tested more than 177,000 serum samples across 52 sites (50 states, DC, and Puerto Rico) between July 27 and September 24 for #SARSCoV2 antibodies. The study found that, in 45 US sites, less than 10% of samples had evidence of previous infection https://t.co/U4hp68fFAx
— JAMA Internal Medicine (@JAMAInternalMed) November 24, 2020